thyroxine has been researched along with Hyperlipoproteinemia Type III in 6 studies
Thyroxine: The major hormone derived from the thyroid gland. Thyroxine is synthesized via the iodination of tyrosines (MONOIODOTYROSINE) and the coupling of iodotyrosines (DIIODOTYROSINE) in the THYROGLOBULIN. Thyroxine is released from thyroglobulin by proteolysis and secreted into the blood. Thyroxine is peripherally deiodinated to form TRIIODOTHYRONINE which exerts a broad spectrum of stimulatory effects on cell metabolism.
thyroxine : An iodothyronine compound having iodo substituents at the 3-, 3'-, 5- and 5'-positions.
Hyperlipoproteinemia Type III: An autosomal recessively inherited disorder characterized by the accumulation of intermediate-density lipoprotein (IDL or broad-beta-lipoprotein). IDL has a CHOLESTEROL to TRIGLYCERIDES ratio greater than that of VERY-LOW-DENSITY LIPOPROTEINS. This disorder is due to mutation of APOLIPOPROTEINS E, a receptor-binding component of VLDL and CHYLOMICRONS, resulting in their reduced clearance and high plasma levels of both cholesterol and triglycerides.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Post-surgical hypothyroidism developed in a now 43-year-old woman with complete insufficiency of the anterior pituitary gland who discontinued levothyroxine replacement therapy." | 3.68 | Expression of type III hyperlipoproteinaemia in a subject with secondary hypothyroidism bearing the apolipoprotein E2/2 phenotype. ( Feussner, G; Ziegler, R, 1991) |
| "The patient was a 65-year-old man with primary hypothyroidism." | 1.30 | Type III hyperlipidaemia with primary hypothyroidism: a unique clinical course of hyperlipidaemia during replacement therapy of thyroid hormone. ( Kobayashi, J; Morisaki, N; Murano, S; Saito, Y; Tashiro, J; Yamazaki, K, 1997) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (33.33) | 18.7374 |
| 1990's | 3 (50.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| FELDMAN, EB | 1 |
| CARTER, AC | 1 |
| FORSTER, G | 1 |
| MUELLER, J | 1 |
| ALSLEBEN, U | 1 |
| BERNHEIM, C | 1 |
| Füessl, HS | 1 |
| Kobayashi, J | 1 |
| Yamazaki, K | 1 |
| Tashiro, J | 1 |
| Murano, S | 1 |
| Saito, Y | 1 |
| Morisaki, N | 1 |
| Crook, MA | 1 |
| Mukherjee, A | 1 |
| Marshall, K | 1 |
| Feussner, G | 1 |
| Ziegler, R | 1 |
6 other studies available for thyroxine and Hyperlipoproteinemia Type III
| Article | Year |
|---|---|
REDUCTION OF SERUM TRIGLYCERIDES IN PATIENTS TREATED WITH SODIUM D-THYROXINE.
Topics: Blood Chemical Analysis; Child; Dextrothyroxine; Glycerides; Hypercholesterolemia; Hyperlipidemias; | 1963 |
[ON THE CLINICAL ASPECTS AND THERAPY OF HYPERLIPEMIA].
Topics: Arteriosclerosis; Cholesterol; Diabetes Mellitus; Diagnosis, Differential; Dietary Fats; Fatty Acids | 1964 |
[Turbid serum].
Topics: Anticholesteremic Agents; Calcium Channel Blockers; Cholesterol; Female; Humans; Hyperlipoproteinemi | 2004 |
Type III hyperlipidaemia with primary hypothyroidism: a unique clinical course of hyperlipidaemia during replacement therapy of thyroid hormone.
Topics: Aged; Bezafibrate; Cholesterol; Humans; Hyperlipoproteinemia Type III; Hypolipidemic Agents; Hypothy | 1997 |
Unusual presentations to a lipid clinic.
Topics: Adult; Apolipoproteins E; Cholesterol, VLDL; Diet, Fat-Restricted; Genotype; Humans; Hyperlipoprotei | 1999 |
Expression of type III hyperlipoproteinaemia in a subject with secondary hypothyroidism bearing the apolipoprotein E2/2 phenotype.
Topics: Adult; Apolipoprotein E2; Apolipoproteins E; Female; Gene Expression; Homozygote; Humans; Hyperlipop | 1991 |